Table 2.
Reasons for switching antipsychotic treatment
| Reason | Number | Percent |
|---|---|---|
| Lack of efficacy | ||
| Alone |
199 |
35.0 |
| In combination with lack of tolerability |
50 |
8.8 |
| Total |
249 |
43.8 |
| Lack of tolerability | ||
| Alone |
319 |
56.2 |
| In combination with lack of efficacy |
50 |
8.8 |
| Total |
369 |
65.0 |
| Lack of tolerability, analytically (n = 369)* | ||
| Weight gain |
149 |
40.4 |
| Extrapyramidal symptoms |
111 |
30.1 |
| Lack of tolerance |
42 |
11.4 |
| Hyperprolactinaemia |
39 |
10.6 |
| Hyperlipidaemia and/or glucose increase |
24 |
6.5 |
| Stress/insomnia/anxiety/akathisia |
16 |
4.3 |
| Sleepiness/drowsiness |
12 |
3.2 |
| Gynecological dysfunctions |
6 |
1.6 |
| Sexual disorders |
6 |
1.6 |
| Other adverse events | 10 | 2.7 |
Asterisk ‘*’ denotes more than one of these reasons may have been selected.